Jonathan Weiss, Associate Director R&D, dPCR Research & Feasibility, QIAGEN
Dr. Jonathan Weiss holds a Diploma in Molecular Biology and a PhD in Molecular Medicine from the University of Cologne, where he worked on deciphering oncogenic dependencies in Non-Small Cell Lung (NSCL) tumors. He then held a postdoc position in Melbourne, Australia, where he started working with digital PCR. He returned to the University Hospital Cologne in 2015 as an independent translational research group leader, where he developed and established digital PCR assays to answer complex clinical questions. He joined QIAGEN in 2023 as an R&D Scientist and he is currently heading the digital PCR Feasibility Group, focusing on new approaches and research to push the limits of digital PCR.
